Sarepta Therapeutics, Inc.
$2.10B- Market cap
- $2.21B
- Debt
- +$828.97M
- Cash
- −$939.65M
Capital structure 73% equity / 27% debt · EV / Revenue 0.96x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
SRPT · price snapshotP/S 1.01x
$20.94Snapshot Sep 8, 2026, 4:00 PM ET
Implied fair value · at WYNN's multiple
$27.6932.2% above market
20.81 SRPT revenue / share×1.33x WYNN P/S=$27.69
Market $20.94Implied $27.69
WYNN · price snapshotP/S 1.33x
$92.22Snapshot Sep 8, 2026, 4:00 PM ET
Implied fair value · at SRPT's multiple
$69.7524.4% below market
69.32 WYNN revenue / share×1.01x SRPT P/S=$69.75
Market $92.22Implied $69.75